Phase 4 Anticoagulant Adverse Reaction Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Atrial FibrillationStrokeAnticoagulant Adverse Reaction+1 more
China National Center for Cardiovascular Diseases4,374 enrolled1 locationNCT06108414
Recruiting
Phase 4
Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
Atrial FibrillationAnticoagulant Adverse ReactionLeft Atrial Appendage Absent
Odense University Hospital1,220 enrolled6 locationsNCT06401616
Recruiting
Phase 4
Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
Atrial FibrillationAnticoagulant Adverse Reaction
Korea University Anam Hospital940 enrolled1 locationNCT06187311